Windlas Biotech Ltd reports Q2FY27 revenue of ₹264 crore, up 19% YoY, with adjusted EBITDA rising 20% to ₹36 crore
- Reported Q2 EBITDA was ₹29 crore (11.1% margin) and net profit ₹18 crore (6.8% margin), each up 1% YoY.
- Excluding ₹6.90 crore of non-cash ESOP expenses, Q2 net profit was ₹25 crore (9.5% margin), up 29% YoY.
- H1FY27 revenue rose 18% to ₹512 crore; adjusted EBITDA was ₹70 crore and adjusted net profit ₹50 crore.